INTRODUCTION
============

Breast-conserving therapy (BCT) is defined as a breast-conserving wide local excision (WLE) of a mammary tumour combined with postoperative radiotherapy \[[@b1-aps-2016-00458],[@b2-aps-2016-00458]\]. The overall survival rate of BCT is equivalent to that of mastectomy for women with early-stage breast cancer \[[@b2-aps-2016-00458],[@b3-aps-2016-00458]\], while preservation of the remaining breast is associated with better psychosocial and psychosexual rehabilitation \[[@b4-aps-2016-00458]\]. Still, BCT is associated with a risk of malformation of the breast, particularly in cases where more than 20% of the mammary volume is excised \[[@b5-aps-2016-00458]\]. The medial quadrants of the breast are especially prone to such a malformation \[[@b1-aps-2016-00458],[@b6-aps-2016-00458]\].

Immediate restoration of the mammary shape by using breast reduction techniques (volume displacement) and immediate restoration of mammary volume by using tissue replacement techniques (volume replacement) are gaining popularity to prevent such malformations \[[@b7-aps-2016-00458]-[@b9-aps-2016-00458]\]. Tissue replacement techniques may, furthermore, prevent the need for symmetrizing contralateral reduction mammoplasty.

We currently utilize an internal mammary artery perforator (IMAP) flap for immediate tissue replacement after WLE in the medial half of the breast. Because the immediate use of the IMAP flap has not been evaluated in a published study, we present our initial experience with its feasibility, preoperative planning, intraoperative details, and pitfalls, and evaluate the surgical and cosmetic outcomes of this technique.

METHODS
=======

Patients
--------

From January 2011 through January 2015, 256 oncoplastic WLEs were performed in 249 women with ductal carcinoma *in situ* (n=56), invasive ductal carcinoma (n=180), or benign tumours (n=13). Breast reduction techniques were applied in 172 of these 249 women, whereas an immediate tissue replacement technique was used in the remaining 77 women. Two women underwent bilateral operations, and 5 others underwent repeated WLE and tissue displacement after an initial non-radical WLE combined with tissue displacement. We used the IMAP flap to replace a mean weight of 46.5 g (median, 36.0 g; standard deviation \[SD\], 30.1 g) of excised medial breast tissue in 12 non-smoking women with a mean age of 56.1 years (median, 55.7 years; SD, 6.2 years) and a mean body mass index of 24.5 kg/m^2^ (median, 23.2 kg/m^2^; SD, 3.9 kg/m^2^) ([Table 1](#t1-aps-2016-00458){ref-type="table"}).

Preoperative planning
---------------------

Preoperative perforator mapping was performed with a unidirectional Doppler probe (8 Hz) with the patient in the supine position. The perforator of the fourth or fifth ipsilateral intercostal space was marked on the skin, approximately 6 to 11 mm lateral to the sternal border \[[@b10-aps-2016-00458]\]. The superior border of the flap was projected in the inframammary fold to assure that the flap would contain abdominal, rather than mammary tissue ([Figs. 1](#f1-aps-2016-00458){ref-type="fig"}, [2](#f2-aps-2016-00458){ref-type="fig"}). The width and inferior border of the skin pedicle flap were established by pinching the inframammary skin and subcutis between the thumb and index finger. The length of the flap could reach the anterior axillary fold, but was preoperatively designed and intraoperatively adjusted depending on the replacement volume needed \[[@b11-aps-2016-00458]\].

Surgical technique
------------------

The women underwent surgery in the supine position with both arms abducted at 90°. Immediately following the WLE and possible axillary node dissection, the skin was incised as planned. The flap was raised from its lateral edge overlying the external oblique muscle towards the rectus fascia, thus approaching the IMAP. Medially, we preserved a skin pedicle in the first 6 women. Propeller flaps were applied in the latter 6 women. Subsequently, the abdominal, caudal edge of the donor flap was raised at a suprafascial level. This edge was then advanced cranially over a vacuum drain towards the inframammary fold using ample subcutaneous quilting sutures. After the lower incision line was situated in the inframammary fold in this way, we fixed it to the fascia with vicryl 2-0 sutures to prevent caudal displacement of the inframammary fold.

The flap was rotated 90° and tunnelled from the inframammary fold into the medial mammary defect. The IMAP flap was de-epithelialized as needed and fixed in the recipient site with vicryl 3-0 sutures in order to prevent dead space ([Figs. 3](#f3-aps-2016-00458){ref-type="fig"}, [4](#f4-aps-2016-00458){ref-type="fig"}). Finally, the skin was closed intracutaneously ([Figs. 5](#f5-aps-2016-00458){ref-type="fig"}, [6](#f6-aps-2016-00458){ref-type="fig"}).

The women were discharged from hospital on the first day after surgery. The drain was left until its production was less than 20 mL/24 hour. Three weeks postoperatively, all patients were seen at our outpatient clinic to evaluate the healing of the breast in order to treat possible complications before adjuvant radiotherapy was started 4 weeks postoperatively.

Follow up and cosmetic evaluation
---------------------------------

Further postoperative assessments were performed routinely at 3 and 6 months after surgery ([Fig. 7](#f7-aps-2016-00458){ref-type="fig"}). Any additional conservative or surgical treatment was noted. All women evaluated the cosmetic outcome and position of the nipple on a scale from 0 (very unsatisfactory) to 10 (very satisfactory), after a median follow-up of 35 months (SD, 1.2 months). They were asked about volume asymmetry compared to the non-operated contralateral breast and about possible pain in the reconstructed breast or donor area. Last, they indicated whether they would choose the oncoplastic approach with an IMAP flap reconstruction again in a similar situation.

RESULTS
=======

We observed no wound dehiscence, infection, (partial) flap loss, or fat necrosis in this series. Consequently, adjuvant radiation treatment did not need to be delayed in any of the women. Because of the non-radical resection of the tumour in 2 of the women, additional radiation therapy was applied in one and a skin-sparing mastectomy in the other. This mastectomy was combined with reconstruction by immediate use of a subpectorally implanted endoprothesis. It was not hampered by the prior tissue replacement approach.

Complementary cosmetic correction of the donor area was performed at the request of 5 of the 12 women ([Table 1](#t1-aps-2016-00458){ref-type="table"}), at a mean of 18.8 months after the primary operation (range, 9--37 months). In all 5 of these women, a pedicled flap rather than a propeller flap had been used primarily. Three of these women underwent adhesiolysis and lipofilling of the donor scar. In 1 of these 3 women, this was combined with lipofilling of the receptor area for a minor deficit of the mammary contour. Correction of a dog-ear deformity at the base of the skin pedicle of the flap was performed under local anaesthesia in the 2 other women, early in the series.

The cosmetic outcome received a mean score of 7.9 out of 10 and the position of the nipple received a mean score of 9.3 out of 10. Two women experienced minimal volume asymmetry in comparison with the contralateral breast and occasional pain located at the donor site. None of the women needed symmetrizing contralateral reduction mammoplasty. All the women would choose the IMAP flap technique again in a similar situation.

DISCUSSION
==========

General advantages and disadvantages of oncoplastic reconstruction after WLE
----------------------------------------------------------------------------

The ultimate goal of oncoplastic WLE is to allow relatively large-volume resections with free margins and fewer re-excisions and additional mastectomies than can be obtained with standard WLE \[[@b12-aps-2016-00458]\]. It allows restoration of breast shape and volume before radiation therapy is started. This results in more patients being satisfied with the cosmetic outcome \[[@b12-aps-2016-00458],[@b13-aps-2016-00458]\]. Consequently, it may prevent secondary, post-radiotherapy surgical correction of mammary malformations \[[@b1-aps-2016-00458],[@b14-aps-2016-00458]\]. Although this combined oncoplastic approach has extended the indications for BCT, its true value for the prevention of local recurrence remains to be determined \[[@b12-aps-2016-00458]\]. Although many guidelines and extensions of indications have been suggested \[[@b1-aps-2016-00458],[@b15-aps-2016-00458]-[@b17-aps-2016-00458]\], there are no standardized practices or guidelines regarding the use of oncoplastic reconstruction \[[@b18-aps-2016-00458]\].

A disadvantage of volume replacement techniques may be donor site morbidity and flap failure \[[@b7-aps-2016-00458]\]. Furthermore, oncological re-operations may be more difficult in cases where the initial excision turns out to have been pathologically non-radical \[[@b12-aps-2016-00458]\].

Development of the IMAP flap
----------------------------

Starting in 1917, IMAP-based flaps have been used, mostly for head and neck reconstruction \[[@b19-aps-2016-00458]\]. The ability of the lower perforating branches of the internal mammary vessels to serve as the vascular pedicle of a true island flap was proven by Kalender et al. \[[@b20-aps-2016-00458]\] when they introduced the use of the IMAP flap for post-burn mammary correction in 2000. Subsequently, the use of this flap was described for secondary contralateral breast reconstruction \[[@b20-aps-2016-00458]-[@b22-aps-2016-00458]\] and the reconstruction of anterior chest wall defects following ablative surgery \[[@b23-aps-2016-00458],[@b24-aps-2016-00458]\]. During preoperative planning, it is not always clear whether the most inferior IMAP or the most superior epigastric artery perforator (SEAP) is included in the flap. Although the potential use of the IMAP or SEAP flap \[[@b23-aps-2016-00458],[@b25-aps-2016-00458]\] for immediate ipsilateral oncoplastic breast reconstruction has been suggested, no reports on this use have been published so far.

Potential limitations of our methodology
----------------------------------------

Before we discuss the clinical implications of our observations, some potential limitations of our report need be addressed. The small number of patients may be explained by the limited incidence of tumours in the medial quadrants of the breast. Still, our mean follow-up of 2.6 years indicates that the use of the IMAP flap for this indication is not just feasible, but successful as well.

A second limitation may be that the successful use of this flap depends on cooperation between an oncological surgeon and a reconstructive surgeon and on both their personal experiences \[[@b1-aps-2016-00458]\]. Hence, our experience may not be easily extrapolated to other clinics, despite the generally increasing interest in oncoplastic techniques.

Clinical implications of our observations
-----------------------------------------

In this series, we replaced the resected tissue of oncologic specimens of a maximum of 125 g (range, 18--125 g; SD, 30.1 g) ([Table 1](#t1-aps-2016-00458){ref-type="table"}). This, however, did not constitute the maximum possible weight of the IMAP, which obviously depends on the body mass index and superior abdominal skin laxity of the patient. In cases where this maximum volume proves insufficient to replace all tissue loss, immediate or secondary additional lipofilling may be performed. Furthermore, the perforator itself may be dissected in cases where additional advancement of the flap is needed, although this did not occur in our series \[[@b19-aps-2016-00458]\].

We observed no flap loss and the overall satisfaction of our patients was good. Adhesiolysis of the scar and dog-ear correction at the donor site were the main reasons for re-operation. To prevent dog-ear corrections in the latter half of this series, we incised the skin pedicle of the flaps and applied the flaps as true propeller flaps in patients number 7 through number 12 ([Table 1](#t1-aps-2016-00458){ref-type="table"}). Although the mean breast cosmesis scores among these latter 6 patients (mean, 8.67; SD, 0.58) were more favourable than those among the 6 patients in whom a pedicled flap was applied (mean, 7.63; SD, 1.19), this difference did not reach statistical significance (P=0.36). We advise the liberal application of quilting sutures when advancing the abdominal edge of the donor site towards the inframammary fold in order to reduce possible traction on this fold and the donor scar.

In conclusion, we chose to use the IMAP flap for medial breast defects because it is a reliable fasciocutaneous local flap with good cosmetic outcomes. The favourable results of using the IMAP flap in breast-conserving surgery widen the applications of this flap, which may lead to a further increase of indications for breast-conserving surgery. Although donor site revision often proved necessary in the first half of this series, we showed this to be easily preventable in the latter half.
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**PATIENT CONSENT**

The patient provided written informed consent for the publication and the use of their images.

![Preoperative design of the IMAP flap\
The design was made with the patient in supine position. X indicates the location of the tumour. IMAP, internal mammary artery perforator.](aps-2016-00458f1){#f1-aps-2016-00458}

![Design of the IMAP flap after WLE\
The small o indicates the IMAP. The large O indicates the WLE defect. IMAP, internal mammary artery perforator; WLE, wide local excision.](aps-2016-00458f2){#f2-aps-2016-00458}

![Rotation and tunneling\
The de-epithelialized IMAP flap was rotated and tunnelled from the inframammary fold into the medial mammary defect. IMAP, internal mammary artery perforator.](aps-2016-00458f3){#f3-aps-2016-00458}

![Rotation and tunneling\
Rotation and tunnelling of the de-epithelialized propeller IMAP flap. The de-epithelialized propeller IMAP flap was rotated and tunnelled from the inframammary fold into the mediocranial mammary defect. IMAP, internal mammary artery perforator.](aps-2016-00458f4){#f4-aps-2016-00458}

![Result immediate postoperative\
The donor site after intracutaneous closure of the skin.](aps-2016-00458f5){#f5-aps-2016-00458}

![Result immediate postoperative\
The donor site after intracutaneous closure of the skin.](aps-2016-00458f6){#f6-aps-2016-00458}

![Result at 6 months after surgery](aps-2016-00458f7){#f7-aps-2016-00458}

###### 

Characteristics of 12 women who underwent wide local excision and oncoplastic reconstruction using an IMAP flap

  Characteristic      Patient number                                                                                                                    
  ------------------- ---------------- --------- --------- --------- --------- ---------- -------------- --------- -------------- ---------- ---------- -----------
  Age (yr)            55.5             56.0      61.6      50.6      55.0      57.8       58.4           59.6      48.6           51.8       70.0       47.7
  BMI (kg/m^2^)       26.5             30.1      33.5      25.5      22.5      21.8       21.2           21.6      23.1           19.6       25.0       23.3
  Site                R                L         R         R         R         R          R              L         R              R          L          R
  TNM class           T1N1             T1N0      T1N0      T2N0      T1N3      DCIS       T1N0           T1N0      T1N0           DCIS       T1N0       Phyllodes
  Weight of WLE (g)   26               67        125       54        33        22         47             39        28             18         71         28
  NAC                 \+               --        --        \+        \+        --         --             --        --             --         --         --
  Pathology           IDC rad          IDC rad   IDC rad   ILC irr   IDC irr   DCIS rad   IDC/DCIS irr   IDC rad   IDC/DCIS irr   DCIS irr   DCIS irr   Phyllodes
  Adjuvant RTh        \+               \+        \+        \+        \+        \+         --             \+        \+             --         \+         --
  Adjuvant HTh        \+               --        --        --        \+        --         --             --        --             --         --         --
  Adjuvant Cth        --               --        --        --        --        --         \+             \+        \+             --         --         --
  Lipofilling         --               --        \+        --        --        \+         --             --        \+             --         --         --
  Dog ear             --               \+        --        --        \+        --         --             --        \+             --         --         --
  Re-excision         --               --        --        --        --        --         \+             --        --             --         --         --
  Breast cosmesis     8                8         7         6         7         7          8              9         8              9          10         mv
  Nipple cosmesis     mv               10        10        7         10        10         7              9         10             10         10         mv

IMAP, internal mammary artery perforator; BMI, body mass index; R, right; L, left; TNM, standard classification of malignant tumors (tumor size-involved lymp nodes-distant metastases); WLE, wide local excision; NAC, neoadjuvant chemotherapy; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; DCIS, ductal carcinoma *in situ*; rad, pathohistologically complete excision; irr, incomplete excision; RTh, radiotherapy; HTh, hormonal therapy; CTh, chemotherapy; mv, missing value.
